GridAI Technologies (GRDX) Operating Leases (2020 - 2024)
GridAI Technologies' (GRDX) quarterly Operating Leases came in at $59024.0 in Q4 2024, down 59.83% on a YoY basis from $146949.0 in Q1 2024, and down 26.42% quarter-over-quarter from $80213.0 in Q3 2024.
Analysis
GridAI Technologies (GRDX) Operating Leases (2020 - 2024) Analysis & Trends
GridAI Technologies (GRDX) has reported Operating Leases for 5 consecutive years, with $59024.0 the latest figure, recorded in Q4 2024.
- For the quarter ending Q4 2024, Operating Leases fell 59.83% year-over-year to $59024.0; the trailing twelve-month figure through Dec 2024 stood at $59024.0 (down 59.83% YoY), and the FY2024 full-year result was $59024.0, down 59.83% from the prior year.
- Operating Leases slipped to $59024.0 in Q4 2024 per GRDX's latest filing, from $80213.0 in the prior quarter.
- Across five years, Operating Leases topped out at $311138.0 in Q4 2021 and bottomed at $6566.0 in Q1 2021.
- Historically, Operating Leases has averaged $163382.4 across 5 years, with a median of $165970.0 in 2023.
- The sharpest annual moves came in 2021 and 2024: Operating Leases surged 1527.04% in 2021, then sank 59.83% in 2024.
- Over 5 years, Operating Leases stood at $19123.0 in 2020, then surged by 1527.04% to $311138.0 in 2021, then slumped by 31.2% to $214060.0 in 2022, then slumped by 31.35% to $146949.0 in 2023, then sank by 59.83% to $59024.0 in 2024.
- According to Business Quant data, Operating Leases over the past three periods registered $59024.0, $80213.0, and $101035.0 for Q4 2024, Q3 2024, and Q2 2024 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn |
| 10 | GridAI Technologies | 19.07 Mn | 19.07 Mn | -36,514.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 59,024.00 |
| Sep 30, 2024 | 80,213.00 |
| Jun 30, 2024 | 101,035.00 |
| Mar 31, 2024 | 127,592.00 |
| Dec 31, 2023 | 146,949.00 |
| Sep 30, 2023 | 165,970.00 |
| Jun 30, 2023 | 184,662.00 |
| Mar 31, 2023 | 196,524.00 |
| Dec 31, 2022 | 214,060.00 |
| Sep 30, 2022 | 231,292.00 |
| Jun 30, 2022 | 310,899.00 |
| Dec 31, 2021 | 311,138.00 |
| Sep 30, 2021 | 295,689.00 |
| Mar 31, 2021 | 6,566.00 |
| Dec 31, 2020 | 19,123.00 |